# GABLOFEN
> **NDA022462** · New Drug Application · Sponsor: PIRAMAL CRITICAL · Approved 2010-11-19
## Drug
- **FDA Application Number:** NDA022462
- **Application type:** New Drug Application
- **Brand name:** GABLOFEN
- **Generic name:** Baclofen
- **Active ingredients:** BACLOFEN
- **Dosage form:** INJECTABLE
- **Route:** INTRATHECAL
- **Marketing status:** Prescription
- **Sponsor:** PIRAMAL CRITICAL
- **First approval:** 2010-11-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022462)
---
*AI Analytics · CC0 1.0*